Literature DB >> 8081362

Genomic organization of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21.

M Bessler1, P Hillmen, L Longo, L Luzzatto, P J Mason.   

Abstract

The PIG-A gene, whose product is involved in one of the early steps in the synthesis of glycan phosphatidylinositol (GPI) anchors, has been recently found to be defective in all cases of paroxysmal nocturnal haemoglobinuria (PNH). By isolating genomic clones from a human phage library we now show that the PIG-A gene consists of six exons (the first of which is non-coding) spanning 17 kb of DNA, and we have mapped the gene to chromosomal position Xp22.1. The PIG-A promoter has features of a housekeeping gene. We have also isolated additional clones which cross-hybridize to PIG-A cDNA, and we have thus identified an intronless PIG-A pseudogene (psi PIG-A), which we have mapped to chromosomal position 12q21. psi PIG-A cannot be functional because it contains several stop codons and a frameshift. These data make it possible to design primers for amplification of the entire PIG-A coding region, with exclusion of psi PIG-A sequences, which will facilitate characterization of PIG-A mutations in patients with PNH. Database searches revealed that PIG-A contains homologies with a number of glycosyl transferases and is highly homologous (45%) to the protein encoded by the yeast SPT14 gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8081362     DOI: 10.1093/hmg/3.5.751

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

1.  X inactivation and somatic cell selection rescue female mice carrying a Piga-null mutation.

Authors:  P Keller; G Tremml; V Rosti; M Bessler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.

Authors:  V Rosti; G Tremml; V Soares; P P Pandolfi; L Luzzatto; M Bessler
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 3.  Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria.

Authors:  Tolulase Olutogun; Ilaria Cutini; Rosario Notaro; Lucio Luzzatto
Journal:  Blood Transfus       Date:  2015-02-02       Impact factor: 3.443

4.  The first step of glycosylphosphatidylinositol biosynthesis is mediated by a complex of PIG-A, PIG-H, PIG-C and GPI1.

Authors:  R Watanabe; N Inoue; B Westfall; C H Taron; P Orlean; J Takeda; T Kinoshita
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

5.  Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism.

Authors:  V C Taylor; M Sims; S Brett; M C Field
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

Review 6.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 7.  Paroxysmal nocturnal haemoglobinuria: nature's gene therapy?

Authors:  R J Johnson; P Hillmen
Journal:  Mol Pathol       Date:  2002-06

8.  Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents.

Authors:  Antonio M Risitano; Bruno Rotoli
Journal:  Biologics       Date:  2008-06

9.  Identification of three novel mutations in the PIG-A gene in paroxysmal nocturnal haemoglobinuria (PNH) patients.

Authors:  A Savoia; L Ianzano; C Lunardi; G De Sandre; M Carotenuto; P Musto; L Zelante
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

10.  Characterization and genomic mapping of the ZNF80 locus: expression of this zinc-finger gene is driven by a solitary LTR of ERV9 endogenous retroviral family.

Authors:  A Di Cristofano; M Strazzullo; L Longo; G La Mantia
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.